Aurobindo Pharma Ltd.
BSE: 524804 | Sector: Health care |
NSE: AUROPHARMA | ISIN Code: INE406A01037 |
BSE 11:40 | 19 Aug | 569.30 |
-13.65 (-2.34%) |
OPEN
588.40 |
HIGH
588.40 |
LOW
569.25 |
NSE 11:29 | 19 Aug | 571.00 |
-12.10 (-2.08%) |
OPEN
583.90 |
HIGH
587.00 |
LOW
570.15 |
OPEN | 588.40 |
PREVIOUS CLOSE | 582.95 |
VOLUME | 25543 |
52-Week high | 767.45 |
52-Week low | 503.40 |
P/E | 23.27 |
Mkt Cap.(Rs cr) | 33,355 |
Buy Price | 569.35 |
Buy Qty | 5.00 |
Sell Price | 569.70 |
Sell Qty | 17.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Aurobindo Pharma Ltd. (AUROPHARMA) - Financial Ratios
Ratios | 2022 | 2021 | 2020 |
Debt-Equity Ratio | 0.18 | 0.27 | 0.34 |
Current Ratio | 1.89 | 1.70 | 1.60 |
Asset turnover ratio | 1.82 | 2.46 | 2.30 |
Inventory turnover ratio | 2.75 | 3.44 | 3.21 |
Debtors turnover ratio | 2.28 | 2.70 | 2.43 |
Interest Coverage ratio | 97.66 | 147.20 | 10.74 |
Operating Margin (%) | 18.34 | 29.76 | 23.09 |
Net Profit Margin (%) | 12.89 | 19.67 | 14.04 |
Return on Capital Employed (%) | 8.49 | 22.94 | 15.97 |
Return on Net Worth (%) | 8.81 | 21.49 | 15.38 |
Quick Links for Aurobindo Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices